| 6:30 a.m. |
– |
7:30 a.m. |
|
Registration/Breakfast |
| 7:30 a.m. |
– |
8:30 a.m. |
|
Session 1: Prize Abstracts |
|
|
|
|
|
|
Moderator: Michael Hsieh, MD, PhD |
|
|
|
|
|
|
Moderator: Jonathan C. Routh, MD |
| 7:30 a.m. |
– |
7:37 a.m. |
|
Presence of Germ Cells in Disorders of Sex Development |
| 7:37 a.m. |
– |
7:44 a.m. |
|
National Trends in Resource Utilization for the Management of Antenatal Hydronephrosis |
| 7:44 a.m. |
– |
7:51 a.m. |
|
Interobserver Reliability in Interpretation of Pediatric Urodynamic Tracings |
| 7:51 a.m. |
– |
7:58 a.m. |
|
Childhood Cancer Risk In The Siblings and Cousins Of Men With Poor Semen Quality |
| 7:58 a.m. |
– |
8:05 a.m. |
|
HDAC8 Plays a Critical Role in Fibroblast Activation and the Pathogenesis of Renal Fibrosis Following Chronic Urinary Tract Obstruction |
| 8:05 a.m. |
– |
8:12 a.m. |
|
Complex Epithelial Transitions Underlie the Fusion Event in Early Fetal Development of the Penile Urethra |
| 8:12 a.m. |
– |
8:19 a.m. |
|
Urinary Proteomic Analysis for Biomarkers to Identify At-Risk Patients with Vesicoureteral Reflux |
| 8:19 a.m. |
– |
8:30 a.m. |
|
Marked Increase in Urinary Excretion of Apolipoproteins in Children with Nephrolithiasis Associated with Hypercalciuria and Hypocitraturia |
|
|
|
|
|
SESSION 2: DSD |
|
|
|
|
|
|
Moderator: Michael J. DiSandro, MD |
|
|
|
|
|
|
Moderator: Margarett Shnorhavorian, MD |
|
| 8:37 a.m. |
– |
8:44 a.m. |
|
Changes in Levels of Parental Distress After their Child with a Disorder of Sex Development Undergoes Genitoplasty |
| 8:44 a.m. |
– |
8:51 a.m. |
|
Attitudes Toward &[Prime]Disorders of Sex Development&[Prime] Nomenclature Among Affected Individuals |
| 8:51 a.m. |
– |
8:58 a.m. |
|
Fertility-related Care for Gender and Sex Diverse Individuals: A Provider Needs-Assessment Survey |
| 8:58 a.m. |
– |
9:05 a.m. |
|
Gene Targeted Chromosome Microarray Analysis in Disorders of Sex Development: Uncovering Small Copy Number Variations Beneath the Surface |
| 9:05 a.m. |
– |
9:12 a.m. |
|
Characterization of Males with Congenital Adrenal Hyperplasia Examined for the Presence of Testicular Adrenal Rest Tumors (TART) |
| 9:12 a.m. |
– |
9:19 a.m. |
|
Predicting the Degree of Virilization in Females with Congenital Adrenal Hyperplasia (CAH) Based on Genotype |
| 9:19 a.m. |
– |
9:26 a.m. |
|
Geographic Variation in Treatment for Patients with Disorders of Sex Development |
| 9:26 a.m. |
– |
9:30 a.m. |
|
Cost Analysis and Clinical Outcomes of Feminizing Genitoplasty on Congenital Adrenal Hyperplasia Using a Large Scale Administrative Database |
| 9:30 a.m. |
– |
10:25 a.m. |
|
DSD Panel: Evolving Role of Patient Advocacy (Multidisciplinary DSD Clinic, Support Groups in Car of Affected Individuals and Their Families, Social Media, Clinician as Patient Advocate) |
|
|
|
|
|
|
Moderator: Jeffrey B. Campbell, MD |
|
|
|
|
|
|
Panelist: Arlene Baratz, MD |
|
|
|
|
|
|
Panelist: Noi Liang, MD |
|
|
|
|
|
|
Panelist: Emily Quinn, MD |
|
|
|
|
|
|
Panelist: Ilene Yi-Zhen Wong, MD |
|
|
|
|
|
BREAK/EXHIBITS |
|
|
|
|
|
|
SESSION 3: DYSFUNCTIONAL VOIDING AND ENURESIS |
|
|
|
|
|
|
Moderator: Paul F. Austin, MD |
|
|
|
|
|
|
Moderator: Dana A. Weiss, MD |
|
| 10:45 a.m. |
– |
10:50 a.m. |
|
Role of Body Mass Index in School-Aged Children with Bladder-Bowel Dysfunction: Does Weight Predict Outcome? |
| 10:50 a.m. |
– |
10:55 a.m. |
|
An Analysis of National Ambulatory Visits and Medication Prescribing Patterns for Pediatric Lower Urinary Tract Dysfunction, 1998-2011 |
| 10:55 a.m. |
– |
11 a.m. |
|
Efficacy and Tolerability of Solifenacin 5mg Fixed Dose in Korean Children with Newly Diagnosed Idiopathic Overactive Bladder: A Multicenter Prospective Study |
| 11 a.m. |
– |
11:05 a.m. |
|
Combined Low Dosed Antimuscarinics for Refractory Detrusor Overactivity in Children |
| 11:05 a.m. |
– |
11:10 a.m. |
|
Outcomes of Sacral Neuromodulation in Children with Dysfunctional Elimination Syndrome and Neurogenic Bladder |
| 11:10 a.m. |
– |
11:15 a.m. |
|
Bladder Training Video (BTV) vs. Standard Urotherapy for Bladder and Bowel Dysfunction: A Non-Inferiority Randomized Controlled Trail (RCT) |
| 11:15 a.m. |
– |
11:20 a.m. |
|
Does a Fully Automatic Voiding Diary Improve Patient’s Compliance and Data Accuracy? Initial Feasibility Pilot Study |
| 11:20 a.m. |
– |
11:25 a.m. |
|
Impact of Procedural Sedation on Outcomes of Pediatric Urodynamic Testing |
| 11:25 a.m. |
– |
11:30 a.m. |
|
The Role of Adenotonsillectomy in the Treatment of Primary Nocturnal Enuresis in Children: A Systematic Review |
| 11:30 a.m. |
– |
11:35 a.m. |
|
Combined Laser Acupuncture and Desmopressin for Treating Resistant Cases of Monosymptomatic Nocturnal Enuresis: A Randomized Comparative Study |
| 11:35 a.m. |
– |
11:40 a.m. |
|
Transcutaneous Electrical Nerve Stimulation: Preliminary Results of a Novel Treatment for Nocturnal Enuresis in Children |
| 11:40 a.m. |
– |
12:15 p.m. |
|
Meredith Campbell Lecture: Mentoring |
|
|
|
|
|
|
Speaker: Laurence S. Baskin, MD |
|
|
|
|
|
LUNCH (NOT PROVIDED) |
|
| 12:15 p.m. |
– |
12:30 p.m. |
|
SFU Business Meeting (SFU Members Only) |
| 1:45 p.m. |
– |
1:48 p.m. |
|
Open Newborn Pyeloplasty – Developing Your Craft and Surgical Education |
|
|
|
|
|
|
Speaker: Max Maizels, MD |
| 1:48 p.m. |
– |
2:45 p.m. |
|
SFU Panel: Prenatal Imaging |
|
|
|
|
|
|
Moderator: Sean T. Corbett, MD |
|
|
|
|
|
|
Panelist: Alan Bailie, MD |
|
|
|
|
|
|
Panelist: Andrew Hull, MD |
|
|
|
|
|
SESSION 4: HYDRONEPHROSIS/PUVS |
|
|
|
|
|
|
Moderator: George Chiang, MD |
|
|
|
|
|
|
Moderator: Micah A. Jacobs, MD |
|
| 2:52 p.m. |
– |
2:59 p.m. |
|
Long-term Impacts of Concomitant Posterior Urethral Valve Ablation and Bladder Neck Incision on Urinary Continence and Ejaculation |
| 2:59 p.m. |
– |
3:06 p.m. |
|
Posterior Urethral Valves: Impact of Low Birth Weight and Preterm Delivery on the Final Renal Outcome |
| 3:06 p.m. |
– |
3:13 p.m. |
|
Natural History and Management of Perinatally Detected Hydronephrosis, Through Long-Term Follow Up |
| 3:13 p.m. |
– |
3:20 p.m. |
|
Isolated Low Grade Prenatally Detected Unilateral Hydronephrosis: Do We Need Long Term Follow Up? |
| 3:20 p.m. |
– |
3:27 p.m. |
|
Association of Initial SFU Grades and UTD Risk Groups with Clinical Outcomes in Patients with Isolated Prenatal Hydronephrosis |
| 3:27 p.m. |
– |
3:34 p.m. |
|
Prediction of Clinical Outcomes in Prenatal Hydronephrosis: What Data Can be Gleaned from Initial Diuresis Renography? |
| 3:34 p.m. |
– |
3:41 p.m. |
|
Renal Parenchyma to Hydronephrosis Area Ratio (PHAR) is a Powerful Predictor of Future Surgical Intervention for Infants with High-Grade Antenatal Hydronephrosis |
| 3:41 p.m. |
– |
3:45 p.m. |
|
Maternal Urinary Carbohydrate Antigen 19-9 as a Novel Biomarker for Evaluating Fetal Hydronephrosis: A Pilot Study |
|
|
|
|
|
BREAK/EXHIBITS |
|
| 4:10 p.m. |
– |
4:40 p.m. |
|
SFU Lecture: Management of PUV |
|
|
|
|
|
|
Speaker: Curtis A. Sheldon, MD |
|
|
|
|
|
SESSION 5: HYDRONEPHROSIS/PUVS |
|
|
|
|
|
|
Moderator: John Gatti, MD |
|
|
|
|
|
|
Moderator: Adam B. Hittelman, MD, PhD |
|
| 4:40 p.m. |
– |
4:45 p.m. |
|
A Practice Pattern Assessment of Members of Society of Pediatric Urology for the Evaluation and Treatment of Urinary Tract Dilation |
| 4:45 p.m. |
– |
4:50 p.m. |
|
Time to Resolution: A Prospective Evaluation from the Society for Fetal Urology (SFU) Hydronephrosis Registry |
| 4:50 p.m. |
– |
4:55 p.m. |
|
Retroperitoneoscopic Assisted Single-Site Pyeloplasty Using EZ Access in Children: Comparison with Open Dismembered Pyeloplasty |
| 4:55 p.m. |
– |
5 p.m. |
|
Dismembered Pyeloplasy in Infants < 6 Months With and Without External Trans-Anastomotic Nephrostent: A Prospective Randomized Study |
| 5 p.m. |
– |
5:05 p.m. |
|
Laparoscopic Versus Open Pyeloplasty in Children: Results of a Randomized, Prospective Controlled Trial |
| 5:05 p.m. |
– |
5:10 p.m. |
|
Enzymatically Active Heparanase Regulates Obstruction-Induced STAT3 Activation and Renal Fibrosis |
| 5:10 p.m. |
– |
5:15 p.m. |
|
Study Of BMP-SMAD Signaling Pathway Involvement in the Etiology of Congenital Anomalies of the Kidney and Urinary Tract, Accompanied by Cryptorchidism, by Using Whole Exome Sequencing |
| 5:15 p.m. |
– |
5:20 p.m. |
|
Impact of De Novo Vesicoureteral Reflux on Transurethral Surgery Outcomes in Pediatric Patients with Ureteroceles |
| 5:20 p.m. |
– |
5:25 p.m. |
|
Bladder Neck Incision in Patients with Posterior Urethral Valve: Do We Need It? |
| 5:25 p.m. |
– |
5:30 p.m. |
|
Ablation of Posterior Urethral Valves in High Risk Patients |
|
|
|
|
|
ADJOURN |
